Literature DB >> 19652373

The protective effect of Daming capsule on heart function in streptozocin-induced diabetic rats with hyperlipidemia.

Jing Ai1, Xinxin Yan, Limei Zhao, Yuan Lu, Feng Liang, Benzhi Cai, Guoyu Li, Yanjie Lu, Baofeng Yang.   

Abstract

Impaired heart function is the main reason for increased mortality of diabetes mellitus. Development of drugs with cardioprotective effects against diabetic myocardiopathy would benefit patients with diabetes. In this study, we tested the cardioprotective effects of Daming capsule (DMC), a traditional Chinese formula, on heart function in streptozocin (STZ)-induced diabetic rats with high fat-diet (HFD). DMC 100 mg/kg/d markedly decreased fasting blood glucose (FBG) and total cholesterol (TC), but did not affect triglycerides (TG) in diabetic rats at 30 d. The decreased heart rate (HR) and prolonged QT and PR interval induced by diabetes mellitus were significantly reversed by DMC (p<0.05). The mechanism may involve that DMC attenuated L-type calcium channel alpha(1c) subunit increasing and Kv4.2 decreasing at both mRNA and protein level in diabetic rats. Additionally, DMC could obviously ameliorate the impaired heart function of diabetic rats by decreasing elevated left ventricular end-diastolic pressure (LVEDP) and increasing the attenuated maximum change velocity of left ventricular pressure in the isovolumic contraction or relaxation period (+/-dp/dt(max)). Transmission electron microscopy (TEM) results showed that myocardium injury was attenuated by DMC (100 mg/kg/d) in STZ-induced diabetic rats with HFD. In conclusion, DMC could recover the prolonged QT interval and PR interval and elevated diastolic and systolic function of diabetic heart. This protective effect may partially be mediated through affecting the mRNA and protein expression of Kv4.2 and alpha(1c) as well as preventing cardiomyocyte morphological remodeling.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19652373     DOI: 10.1248/bpb.32.1354

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  5 in total

1.  Influence of fluvastatin on cardiac function and baroreflex sensitivity in diabetic rats.

Authors:  Fang Xie; Chao Sun; Li-hua Sun; Jing-yuan Li; Xin Chen; Hui Che; Guan-yi Lu; Bao-feng Yang; Jing Ai
Journal:  Acta Pharmacol Sin       Date:  2011-03       Impact factor: 6.150

2.  Protective effect of the daming capsule on impaired baroreflexes in STZ-induced diabetic rats with hyperlipoidemia.

Authors:  Jing Ai; Li-Hong Wang; Rong Zhang; Guo-Fen Qiao; Ning Wang; Li-Hua Sun; Guan-Yi Lu; Chao Sun; Bao-Feng Yang
Journal:  BMC Complement Altern Med       Date:  2010-12-22       Impact factor: 3.659

3.  Daming capsule restores endothelial dysfunction induced by high-fat diet.

Authors:  Rong Zhang; Huifang Niu; Ning Wang; Lihua Sun; Yi Xu; Ruibo Zhao; Xiang Ban; Yao Yu; Baofeng Yang; Jing Ai
Journal:  BMC Complement Altern Med       Date:  2012-03-24       Impact factor: 3.659

4.  Protective effect of Daming capsule against chronic cerebral ischemia.

Authors:  Xiaodan Song; Wenliang Zhu; Ran An; Yamei Li; Zhimin Du
Journal:  BMC Complement Altern Med       Date:  2015-05-14       Impact factor: 3.659

5.  The anti-hyperglycemic efficacy of a lipid-lowering drug Daming capsule and the underlying signaling mechanisms in a rat model of diabetes mellitus.

Authors:  Yong Zhang; Xiaoguang Li; Jiamin Li; Qingwei Zhang; Xiaohui Chen; Xin Liu; Yue Zhang; Haiying Zhang; Huan Yang; Yingying Hu; Xianxian Wu; Xin Li; Jiaming Ju; Baofeng Yang
Journal:  Sci Rep       Date:  2016-10-10       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.